MeSH term
Frequency | Condition_Probility | Adolescent | 9 | 0.0 |
Adult | 14 | 0.0 |
Case-Control Studies | 6 | 0.0 |
Child | 6 | 0.0 |
Humans | 59 | 0.0 |
Male | 24 | 0.0 |
Middle Aged | 15 | 0.0 |
Nitric Oxide/*metabolism | 6 | 4.0 |
Nitric-Oxide Synthase/*metabolism | 6 | 7.0 |
Animals | 19 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Comparative Study | 11 | 0.0 |
Rats | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 38 | 0.0 |
Aged | 8 | 0.0 |
Immunohistochemistry | 8 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Alleles | 13 | 0.0 |
Female | 23 | 0.0 |
Genotype | 13 | 0.0 |
Phenotype | 7 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Breath Tests | 2 | 2.0 |
English Abstract | 3 | 0.0 |
Asthma/*genetics | 3 | 5.0 |
*Chromosome Mapping | 2 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Exons | 6 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Introns | 3 | 0.0 |
Nitric-Oxide Synthase/genetics | 5 | 14.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
*Chromosomes, Human, Pair 12 | 3 | 1.0 |
Linkage (Genetics) | 2 | 0.0 |
Mice | 9 | 0.0 |
Nitric-Oxide Synthase/*genetics | 19 | 19.0 |
Isoenzymes/biosynthesis | 2 | 4.0 |
Nitric-Oxide Synthase/*biosynthesis | 3 | 10.0 |
Cells, Cultured | 3 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Base Sequence | 6 | 0.0 |
DNA/genetics | 2 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Nerve Tissue Proteins/*genetics | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 5 | 0.0 |
Statistics, Nonparametric | 3 | 0.0 |
Cohort Studies | 2 | 0.0 |
Gene Frequency/genetics | 4 | 0.0 |
Nitric Oxide/*physiology | 5 | 6.0 |
Nitric-Oxide Synthase/metabolism | 2 | 1.0 |
Aged, 80 and over | 2 | 0.0 |
Asthma/*enzymology/*genetics/immunology | 2 | 66.0 |
Dinucleotide Repeats/genetics | 3 | 7.0 |
Immunoglobulin E/blood | 2 | 1.0 |
Logistic Models | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
United States | 2 | 0.0 |
Great Britain | 2 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Reference Values | 3 | 0.0 |
Mutation | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Neurons/*enzymology | 4 | 5.0 |
Chi-Square Distribution | 3 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Gene Frequency | 6 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Histocytochemistry | 2 | 0.0 |
Infant | 2 | 0.0 |
Nitric-Oxide Synthase/genetics/*metabolism | 3 | 17.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Nitric Oxide/metabolism | 2 | 1.0 |
Amino Acid Sequence | 2 | 0.0 |
Chromosomes, Human, Pair 12/*genetics | 2 | 1.0 |
*Linkage (Genetics) | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Amino Acid Oxidoreductases/*genetics | 2 | 12.0 |
DNA Primers | 2 | 0.0 |
Nitric-Oxide Synthase | 2 | 5.0 |
Child, Preschool | 2 | 0.0 |
Japan | 2 | 0.0 |
Superoxide Dismutase/metabolism | 2 | 2.0 |
Time Factors | 2 | 0.0 |
Thioredoxin/*metabolism | 2 | 18.0 |
